Dimensional Fund Advisors LP Organogenesis Holdings Inc. Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,104,550 shares of ORGO stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,104,550
Previous 3,100,396
0.13%
Holding current value
$14.1 Million
Previous $13.4 Million
15.16%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ORGO
# of Institutions
123Shares Held
72MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.3MShares$55.9 Million3.5% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN6.78MShares$30.7 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...